Category: Pharmacy Benefits
Hidden Opportunities, A Strategic Compliance Series
Hidden Opportunities Overview
In this webinar series we explore ways organizations can go beyond basic compliance and improve their “organizational soil” through a strategic response to the No Surprises Act and the Transparency in Coverage regulations. Our goal is to help organizations create a competitive advantage. Does it make sense to expend limited resources to merely comply with the law and regulations, or is there a way to strategically “design the compliance away” while differentiating the employee value proposition?
For example, a knowledgeable horticulturist may use the high temperatures of the summer season, which are a normal part of the environment just as law and regulation are a normal part of the business environment, to solarize the soil. This is a low cost and simple process of spreading a plastic sheet over an area of soil to trap and intensify the sun’s energy. It is a process that works well to destroy weed seeds and pathogens. Similarly, a knowledgeable Humaculturist® can employ techniques to leverage laws and regulations to strategically improve the organization. This webinar series seeks to identify some of these techniques.
The topics from the series include:
| Hidden Opportunities: No Surprises Act |
| Surpassing Mere Compliance – Including Reference Based Pricing |
| Preserving the Harvest…Leveraging HSAs |
| Hidden Opportunities: Transparency |
| A “Dope” Response to Pharmacy Transparency |
| Mental Health Parity…A Lucid Approach |
| Pest Management, Minimizing Plan Losses through Fee Disclosure |
Available Support
We are available to support you in your strategy, design, compliance, financial, and monitoring needs. Our team includes experts in organization design, actuarial science, clinical, and legal can guide the process to achieve optimal behavior. Please contact us.
Webinar Replay: A “Dope” Response to Pharmacy Transparency
Watch a replay of the third webinar in Humaculture, Inc.’s Hidden Opportunities, Strategic Compliance Series, which focuses on why the new pharmacy transparency law will not increase transparency; will increase costs, administration, and litigation risk; and how to effectively respond.
Presenters
- Steve Cyboran, ASA, MAAA, FCA, CEBS, actuary and strategy consultant
- Wes Rogers, Humaculturist® and strategy consultant
- Jack Towarnicky, LLM, JD, MBA, CEBS, attorney, strategy and compliance consultant
- Scott McKibbin, strategy and pharmacy consultant
Objective
Beyond basic compliance, this series addresses how to strategically leverage the No Surprises Act to create a competitive financial advantage for both the plan sponsor and plan participants. This session focuses on leveraging Acquisition Cost Based Pharmacy Pricing as well as Behavioral Design and Messaging as an example of a strategic action organizations can take to optimize this compliance opportunity.
Pharmacy Transparency Key Takeaways
During this session, participants will learn:
- Transparency is a misnomer – New rules don’t provide transparency
- Pharmacy is likely to continue to be rather “opaque”
- The conundrum – mere compliance will likely increase costs, administration, and litigation risk
- How to use Acquisition Cost Based Pharmacy Pricing as well as Behavioral Design and Messaging as examples of strategic actions to:
- Avoid what can be avoided
- Provide true transparency with pharmacy benefits
- Empower consumers to make better, more clinically appropriate decisions
- Communicate all negatives as the result of compliance
- Inform/educate consumers (before they become patients)
Available Support
We are available to support you in your strategy, design, compliance, financial, and monitoring needs. To that end, our team of consultants, including actuaries, clinicians, behavioral health, pharmacy, and legal resources are available to guide you through the compliance process. Please contact us: [email protected].
Watch
Watch the Hidden Opportunities: Preserving the Harvest…Leveraging HSAs Webinar Replay below, or via Rumble or YouTube.
Hidden Opportunities, A Strategic Compliance Series: A “Dope” Response to Pharmacy Transparency
You can now access a replay of this webinar here.
Join us on Thursday, March 17 from 12:00 to 12:30 CST for the third webinar in Humaculture, Inc.’s Hidden Opportunities, Strategic Compliance Series, to learn why the new pharmacy transparency law will not increase transparency; will increase costs, administration, and litigation risk; and how to effectively respond.
Presenters
- Steve Cyboran, ASA, MAAA, FCA, CEBS, actuary and strategy consultant
- Wes Rogers, Humaculturist® and strategy consultant
- Jack Towarnicky, LLM, JD, MBA, CEBS, attorney, strategy and compliance consultant
- Scott McKibbin, strategy and pharmacy consultant
Objective
Beyond basic compliance, this series addresses how to strategically leverage the No Surprises Act and Transparency in Coverage to create a competitive advantage for both the employer and employees. In this session we will include a focus on leveraging Acquisition Cost Based Pharmacy Pricing as well as Behavioral Design and Messaging as an example of a strategic action organizations can take to optimize this compliance opportunity.
Pharmacy Transparency Key Takeaways
During this session, participants will learn:
- Transparency is a misnomer – New rules don’t provide transparency
- Pharmacy is likely to continue to be rather “opaque”
- The conundrum – mere compliance will likely increase costs, administration, and litigation risk
- How to use Acquisition Cost Based Pharmacy Pricing as well as Behavioral Design and Messaging as examples of strategic actions to:
- Avoid what can be avoided
- Provide true transparency with pharmacy benefits
- Empower consumers to make better, more clinically appropriate decisions
- Communicate all negatives as the result of compliance
- Inform/educate consumers (before they become patients)
